Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI Worldwide, MilanCPhI Worldwide, Milan
Not Confirmed
Not Confirmed
08-10 October, 2024
Not Confirmed
Not Confirmed
28-30 September, 2024
Discovery on TargetDiscovery on Target
Not Confirmed
Not Confirmed
30 September-03 October, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI Worldwide, MilanCPhI Worldwide, Milan
Industry Trade Show
Not Confirmed
08-10 October, 2024
Industry Trade Show
Not Confirmed
28-30 September, 2024
Discovery on TargetDiscovery on Target
Industry Trade Show
Not Confirmed
30 September-03 October, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/ice-is-pioneering-sustainability-innovation-in-bile-acid-research-for-neurodegenerative-diseases
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/2024-us-elections-harris-trump-differ-on-abortion-rights-aca-public-health-spends-agree-on-need-to-cut-drug-prices
08 Jun 2024
// PHARMABIZ
14 Sep 2022
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2022/09/14/2516211/0/en/Sermonix-Pharmaceuticals-Shares-Details-of-First-Ever-Known-Durable-Complete-Clinical-Response-in-a-Metastatic-ER-HER2-Breast-Cancer-Patient-With-an-ESR1-Mutation-After-Prior-CDK4-.html
13 Sep 2022
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2022/09/13/2515038/0/en/Sermonix-Pharmaceuticals-Announces-Results-of-Phase-2-Study-of-Lasofoxifene-vs-Fulvestrant-in-Postmenopausal-Women-With-Locally-Advanced-or-Metastatic-ER-HER2-Breast-Cancer-and-an-.html
27 Nov 2021
// FINSMES
https://www.finsmes.com/2021/11/sermonix-pharmaceuticals-raises-40m-in-series-a3-funding.html
21 Apr 2021
// GLOBENEWSWIRE
http://www.globenewswire.com/news-release/2021/04/21/2214280/0/en/Sermonix-Pharmaceuticals-Project-With-Huntsman-Cancer-Institute-Researcher-to-Investigate-Potential-Effects-of-Lasofoxifene-on-ESR1-Mutations-in-Endometrial-Cancer.html
04 Dec 2020
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2020/12/03/2139311/0/en/Sermonix-to-Present-Poster-on-Phase-2-Study-of-Lasofoxifene-in-Combination-with-Eli-Lilly-and-Company-s-Abemaciclib-at-Virtual-San-Antonio-Breast-Cancer-Symposium-2020.html
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?